✦ LIBER ✦

Long-duration therapy with low molecular weight heparin in patients with antiphospholipid antibody syndrome resistant to warfarin therapy

✍ Scribed by F. DENTALI; E. MANFREDI; M. CROWTHER; W. AGENO

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Strategies for Managing Heparin Therapy

✍ Dr. Trupti P. Mehta; Dr. Maureen A. Smythe; Dr. Joan C. Mattson 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 216 KB

Thromboprophylaxis with low-molecular we

✍ S.G. Ismailova; V.O. Bitsadze; A.D. Makatsaria 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 160 KB

“Bridging” Therapy with Low Molecular We

✍ James B. Groce III 📂 Article 📅 2003 🏛 Springer US 🌐 English ⚖ 71 KB

Use of Low-Molecular-Weight Heparin to B

✍ Ms. Kirsten L. George-Phillips; Dr. Tammy J. Bungard 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB

Clinical outcomes with unfractionated he

✍ A. C. SPYROPOULOS; A. G. G. TURPIE; A. S. DUNN; J. SPANDORFER; J. DOUKETIS; A. J 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB

Orbital Hemorrhage and Compressive Optic

✍ Basem T. Jamal; Robert J. Diecidue; Daniel Taub; Allen Champion; Jurij R. Bilyk 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 580 KB